GSK plc
Global biopharma company focused on vaccines, specialty medicines and consumer healthcare products.
Financial Snapshot
The GSK plc Story Through Numbers
GSK's Destiny 7 energy β research, analysis and the pursuit of proprietary knowledge β drives a pharmaceutical and vaccine business built on intellectual property accumulated over nearly 300 years of combined company history. The 2022 separation of consumer health into Haleon was a 7's decision to focus: strip away the noise, concentrate on the deep science of vaccines and specialty medicines where analytical depth creates defensible advantage. The Shingrix success β a blockbuster shingles vaccine with over 90% efficacy β is a 7 company doing what 7s do best.
Investor alignment: Best aligned with Life Path 7 research-oriented investors and Life Path 6 health-focused shareholders who value preventive medicine.